ABSTRACT
INTRODUCTION
The mechanism of drug action generally involves a long chain of interactions with the molecules of the human body. There are numerous experimental and in silico drug design tools describing the terminal link of these chains, i.e. the estimation of equilibrium binding affinities (BA) of drug candidates (ligands) to the targeted macromolecules. Although BA is undoubtedly a key property, other pharmacokinetic and non-equilibrium links in the chain such as absorption, distribution, and excretion of the candidate molecules also affect drug-likeness (Swinney 2004 , Swinney 2006 . Accordingly, most of the current in silico molecular design strategies (Lipinski and Hopkins 2004) include modeling steps for the equilibrium binding and also for the pharmacokinetics of drugs. Atomic level techniques have been introduced for structural calculation of binding in ligand-target complexes. Computational molecular docking (Fig. 1) is the most advanced among these techniques (Brooijmans and Kuntz 2003) . The BA values of the ligands can be calculated directly from docked ligand-protein complex structures with free energy (scoring) functions. Another important step is the optimization of pharmacokinetics and druglikeness of ligand databases using empirical rules of selection (Lipinski et al. 1997) . These rules define limit values of simple, sizedependent molecular descriptors, e.g. the molecular weight (M W ) which can be used for filtering of compound databases.
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Recently, new measures, the efficiency indices (EI) were introduced (Abad-Zapatero and Metz 2005, Hopkins et al. 2004 ) linking the above mentioned different steps of drug design. EI's have promptly gained applications connecting structural diversity and biological activity of drugs (Schuffenhauer et al. 2006 ) and in optimization of synthetic receptors (Chen et al. 2006) . The introduction of EI's was inspired by earlier studies showing the usefulness of normalization of BA with the number of heavy atoms (N HAT ) for drug design purposes. (Yang and Tung 2006) . To efficiently use this increasing amount of 3D information for drug design, high throughput methods are necessary, which can reduce the complexity of drug (ligand)-protein interactions to comparable measures (indices). The sequence of grey boxes show, that starting from the 2D Lewis structures of a ligand, 3D ligand-protein complexes can be obtained via conversion, modeling and docking. In the present study (beige boxes), a set of biologically relevant ligand-protein complexes were used for calculation of binding free energy (∆G C ). A representative complex of β-secretase (blue), a key enzyme of Alzheimer's disease and its potent peptidic inhibitor ligand, GluValAsnLeu(Ψ)AlaAlaGluPhe (red) is included in this figure. Further references on the role of β-secretase can be found in works of Hetényi et al. (2006) and Hong et al. (2000) . Both 2D and 3D representation of the ligand molecules can be used for calculation of size-dependent normalization factors (SNF). The ratio of ∆G C and SNF is the efficiency index, which is a practical 'two-in-one' measure of drug design. This figure was prepared using PyMol (DeLano 2006). In EI's, the normalized quantities (Eq. 1) are represented by commonly used measures of BA such as the experimental free energy of binding (∆G E ), the negative logarithms of experimental dissociation constant (pK d ), inhibition constant (pK i ) or inhibitor concentration at 50 % inhibition (pIC 50 ). The above mentioned simple descriptors, i.e. M W (Abad-Zapatero and Metz 2005) or N HAT are typical examples of the size-dependent normalizing factors (SNF). (Fig. 1) . In both cases it requires negligible time and, therefore, allows reduction of time-consuming and expensive biochemical measurements of BA's. Picking up the speed of in silico docking and scoring, the calculation of EI's can become an essential part of high throughput, structure-based virtual compound screening and drug design. The aim of the present study is to introduce and investigate rapid calculation of various EI's on the basis of a set of biologically relevant structural and thermodynamic experimental data.
METHODS
Binding data and structure-based free energy calculation of protein-ligand systems. ∆G E and ∆G C values of 53 protein-ligand complexes were adopted from a previous study (Hetényi et al. 2006 ) and listed in Supplementary Information. Proteins having large, peptidic ligands (M W >350) and physiological importance such as the β-secretase enzyme of Alzheimer's disease (Fig. 1) , HIV-1 protease, streptavidin, and immunoglobulins were prioritized for the study. The atomic coordinates of 41 of the complexes, were obtained from the Protein Databank (PDB, Berman et al. 2000) . 12 β-secretase-inhibitor systems (om12, om13, om14, om15, om16, om17, om18, om19, om22, om23, om24 and om99-1) with no PDB structures available were modeled by modification of the 1fkn structure. Details on the systems, modeling and minimization of the complexes can be found in the previous paper (Hetényi et al. 2006) . Although the peptidic ligands of these systems may become excellent lead compounds, they cannot be considered as drugs (Rishton 2003 
The f coefficients were determined empirically from a multi-linear regression (MLR) to a set of 30 protein-ligand complexes (AutoDock calibration set) with known binding constants (Morris et al. 1998) . The indices i and j correspond to ligand and protein atoms, respectively. The Coulombic term includes the partial charges (q) and a distance-dependent dielectric function (ε) (Morris et al. 1996) . A, B, C and D are the Lennard-Jones parameters in the dispersion/repulsion 12-6 and H-bonding 12-10 formulas and r denotes the distance between the atomic pairs. ξ(t) is a directional weight depending on angle t at the H-bonds. S and V denote the solvation parameter and fragmental volume, respectively, in the solvation function of Stouten et al. (1993) . In the scoring function of AutoDock 3.0, only the C atoms of the ligand molecules are involved in the solvation model. The exponential term is an envelope function with a constant-value of σ=3.5 Å. For simplicity, the sum of Coulombic and Lennard-Jones (enthalpic) terms is marked as ∆H C and the last, desolvation term is marked as ∆G s,C . Remarkably, the AutoDock4 scoring function has different parametrization of the ∆G C (AD4) part, especially for the desolvation term. Details on the new AD4 scoring function can be found in the original paper of Huey et al. (2007) . In the present study, all systems were re-scored using the epdb command of AutoDock4. Besides the ∆G C (AD4), i.e. the intermolecular enthalpic+desolvation terms, the full AD4 binding free energy (∆G full (AD4)) was also calculated and checked for applicability in EI calculations. Regression analyses. The LR's were statistically analyzed and the SNF values were obtained using the program package CODESSA (ver. 2.0) (Katritzky et al. 1995 . Results of the regression analyses, i.e. mean square errors and t-values of the regression coefficients, the F-values, and the squares of the correlation coefficients (r 2 ) of the regressions are tabulated in section
Results. The principal moments of inertia were calculated for the binding conformations of ligand molecules using the Analyze program of the TINKER software package (Ren and Ponder 2003) . Numerical values used in the calculations and the correlations of SNF's are tabulated in Supplementary Information. 
RESULTS

Definition of new EI
Where α, and β represent the regression coefficient and the intercept, respectively. The ε k 's are the residuals at each data point. The total number of data points (N), i.e. the number of protein-ligand systems adopted from the previous study (Hetényi et al. 2006 ) was 50. A systematic series of LR's were developed for EI's based on the SNF's of Table 2 and ∆G C 's calculated with the scoring schemes of AutoDock3.0 and AutoDock4, respectively. The results and statistical parameters of the LR's are summarized in Table 3 and in the Supplementary Information. (Hetényi et al. 2006) . Importantly, the high r 2 values in Table 3 are not trivial consequences of this correlation in the previous work, as the SNF values are different for the 50 different ligand molecules (Eq. 3). An advantage of 2D descriptors such as the Wiener index (W) involved in the best correlation (Fig. 2, Table 3 ) is that they can be unambiguously and rapidly calculated from the internal connectivity information coded in the molecular graph (Table 2) . For example, W involves a simple summation of shortest topological distances in a molecule. Comparably good correlations could be achieved at all other SNF's including Balaban index (J) which is also defined by internal topological distances (Table 2 ) and was found to be useful as a QSAR descriptor in prediction of the entropic parts of ∆G E (Hetényi et al. 2006 ). In addition, even the three outlier protein-ligand systems (1hhj, om22, om24) of the previous study (Hetényi et al. 2006 ) could be involved in the models (N=53 in Eq. 3). In case of W the level of correlation (r 2 =0.962) did not decrease when the three former outliers were included. Cross-validation of the correlations. There were different methods applied for cross-validation of the correlations presented in Table  3 . The cross-validated correlation coefficients (r 2 cv ) of the leaveone-out (LOO) and leave-50%-out (L50%O) methods (Table 3) shows that exclusion of one or more data points from the models does not decrease the level of correlation dramatically. A set of 20 drug-protein complexes (Table 1) was used as an external validation set (EXT). Most of the corresponding r 2 values are above 0.5 showing that the models can predict the EI values for smaller, drug ligands not included in the training set (50 systems). Notably, ∆G C (AD4) produced higher r 2 cv (EXT) values for the external validation than ∆G C (AD3), probably due to the more advanced solvation terms and the larger compound database included in its parametrization. The ∆G full (AD4) function did not result better EIcorrelations (data not shown) than ∆G C (AD4), and, therefore ∆G C (AD4) was selected for the final evaluations (Table 3) .
The results of the cross-validated correlations in Table 3 let us conclude that structure-based calculation of EI's works for both the 'traditional' (Abad-Zapatero and Metz 2005, Hopkins et al. 2004) and the newly introduced 2D SNF's (W, χ's, J, etc.). The formulas in Eq. 3 and Table 2 and the validated models can be coded and applied as EI-calculators during the in silico drug design process (Fig. 1) . Direct implementation of EI-calculator algorithms in docking/scoring program packages such as AutoDock is also possible. Applications. (1) To check the applicability of two new EI's with the best correlations (Table 3) the distributions of ∆G E and EI values were compared for the sets including the 50 peptidic compounds (nondrugs) and the 20 drugs, respectively. It was found (Fig. 3 and Supplementary Information) that overlapping distributions of ∆G E 's (Fig. 3A) of drugs and nondrugs are separated for the EI's (Fig. 3B ). There is one or two order of magnitude difference (Table 4) in the median/average values of EI's for both W and I A I B I C and there are considerably large gaps between the minimum values of drugs and nondrugs, as well. These results emphasize the applicability of the new EI's in separation of drugs from nondrugs. (2) The introduction of EI's in a virtual screening process improves the selectivity of screening. As a test case, the binding pocket of progesterone receptor was used as a target in the docking of 1760 compounds including an abridged version of the NCI Diversity Set (NCI/NIH, Lindstrom et al. 2003 ) and the native drug ligand norethindrone (1sqn, Table 1 ). ∆G C 's were collected and W-and I A I B I C -based EI's were calculated. Details on the methods of these procedures are described in the Supplementary Information. It was found, that the use of ∆G C 's alone ranked norethindrone to the best 10 % of the 1760 compounds. Re-ranking of the best 10 % according to W-and I A I B I C -based EI's resulted norethindrone in the 2 nd and 6 th best position (< top 0.5 %) on the list of the 1760 compounds, respectively. This test showed that in a second ranking step these new EI's can improve the quality of selection of a real drug. 
DISCUSSION
The background of the thermodynamics of EI's. The binding free energy (∆G) can be written as the sum of experimental enthalpic (∆H) and entropic (∆S) binding contributions (Eq. 4), where T is the thermodynamic temperature.
∆G = ∆H -T∆S (4)
As an additive quantity, ∆S can be further split into translational (∆S t ), rotational (∆S r ), and vibrational (∆S v ) entropy changes (Eq. 5) at the ligand molecule. In some articles (Noskov 2001) , further contributions are also considered such as solvation/desolvation free energy (∆G s ) of the ligand and/or the protein molecules, etc. As the SNF's depend solely on the ligands, involvement of protein effects is not necessary in the forthcoming discussion.
The use of statistical thermodynamics expressions (Carlsson and Åqvist 2005, Murray and Verdonk 2002) for estimation of components S t , S r (Table 5 ) and S v of molecular entropy is quite common. S v depends on the frequencies of normal modes of the ligand molecule, which cannot be connected with the simple SNF's of this study. ∆G s includes both enthalpic and entropic contributions (Zou et al. 1999) and partly depends on the molecular size and shape of the ligand via the solvent accessible surface area. Accordingly (Eq. 5), the division of ∆G E (left side of Eq. 3) with SNF's results in normalized ∆H E 's and ∆S E 's. On the right side of Eq. 3 there is ∆G C (Eq. 6), including three terms (Eq. 2, Methods), which can be assigned (Brooijmans and Kuntz 2003, Calderone and Williams 2001) to the enthalpic (∆H C ) contributions of binding. The fourth term of ∆G C (∆G s,C ) is an estimate of ∆G s which represents only a minor portion of ∆G C (Eq. 6).
Thus, the SNF-normalized ∆G C (Eqs. 3 and 6) contains mostly normalized ∆H C (and neglibible ∆G s,C ). Most importantly, there are no terms estimating ∆S t , ∆S r , and ∆S v on the right side.
If assuming that experimental entropy (S E ), i.e. S t and S r becomes zero after ligand binding, then ∆S t and ∆S r will include sizedependent factors, such as M W or the product of principal moments of inertia (I A I B I C ), respectively (Table 5 ). However, it was correctly discussed (Carlsson and Åqvist 2005) , that the assumption of zero final entropy is rather hypothetical as the ligand does fluctuate around its binding position. Whereas the formulas of Table 5 Table 1 ).
The constant part of SNF-normalized ∆S E does not affect the level of correlation and the remaining SNF-normalized enthalpic terms in Eq. 3 correlate well with each-other (Table 3) . New 3D SNF's. To test the prediction of the previous section, i.e. the usefulness of I A I B I C as a 3D SNF, it was employed in Eq. 3. The statistical parameters of the corresponding LR (Table 3 , Supplementary Information) show an excellent correlation (r 2 =0.966) verifying the expectation. Remarkably, both the 3D I A I B I C and the 2D W involve the calculation of real or topological internal lengths of the ligand molecules, and, therefore their connection is trivial. Their correlation for the 50 ligands is r 2 =0.864. Interestingly, the 2D W performed as well (Table 3) as the obviously more elaborate 3D I A I B I C in case of the 50 systems. It was also found, that I A I B I C works even for smaller sub-sets of the 50 investigated systems resulting in e.g. an r 2 of 0.973 for the 10 modeled β-secretase complexes alone (AD3 scoring). Other internal distance-based 3D SNF's such as the gravitation index (GI), a descriptor successful in prediction of boiling points ) also provided good LR results in calculation of EI's (Table 3) . Methodological aspects of the results. Scoring functions of docking programs are generally based on correlations of ∆G E with ∆G C . However, during the development of scoring functions, separate fit of experimental ∆H E and ∆S E to the corresponding enthalpic and entropic terms (Brooijmans and Kuntz 2003) of the scoring functions would be an ideal way (Murphy 1999) to decrease errors coming from overlapping and/or coupled terms. However, most of the experimental thermodynamic BA data available are ∆G E values or pK's from which ∆G E 's can be calculated (Wang et al. 2004) . The amount of enthalpic data is limited as experimental binding enthalpy (∆H E ) can be obtained only by additional measurements with special techniques, e.g. isothermal titration calorimetry (Cam-poy and Freire 2005) . The LR's of the previous sections showed, that the SNF-normalization of ∆G E provides excellent correlation with the normalized ∆H C without additional measurements of ∆H E , due to the high enthalpic content of both sides of Eq. 3 (see previous sections for details). It can also be recognized (Eq. 3), that the reciprocals of the SNF's are actual weights in the weighted least squares fit of the calculated enthalpic terms to the experimental ∆G E 's. By using these weights during development of scoring functions, the degree of correlation and the accuracy of computational docking-scoring methods can be increased. Practical applications. The EI's are simple indicators developed to aid rational drug design and hit-to-lead approaches (Keserű and Makara 2006) . In the present study, new EI's involving 2D and 3D SNF's were introduced. It was shown, that precise, structure-based calculation of EI's is a real alternative of time-consuming measurements and that the new EI's can be used in separation of drugs from nondrugs. The calculation of EI's of a large set of available drugs will allow the determination of reference EI-limits for selection of drug-like candidates in the future. The building of an EI database for the precise determination of EI-limits has already been started in our laboratory. As the proposed EI-calculators are fast and cost-effective, they will help to reduce the number of experimental measurements and can easily be combined with available methods in high throughput computational docking and scoring (Fig. 1) .
